These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 36357)

  • 1. Clinical studies of thyrotropin-releasing hormone tartrate (TRH-T) as a direct stimulant to the central nervous system.
    Ogashiwa M; Takeuchi K
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):145-51. PubMed ID: 36357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies of thyrotropin-releasing horomone tartrate (TRH-T) as a direct stimulant to the central nervous system (author's transl)].
    Ogashiwa M; Takeuchi K
    Rinsho Shinkeigaku; 1977 Oct; 17(10):655-64. PubMed ID: 413683
    [No Abstract]   [Full Text] [Related]  

  • 3. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ; Rosenbaum RL; Pan C; Surks MI
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M; Ogawara K; Takaya Y; Hayashi M
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a continuous thyrotropin-releasing hormone infusion on gonadotropin-releasing hormone-stimulated gonadotropin secretion.
    McDermott MT; Sjoberg RJ; Hofeldt FD; Kidd GS
    J Lab Clin Med; 1990 Aug; 116(2):187-90. PubMed ID: 2118558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.
    Snyder PJ; Utiger RD
    J Clin Invest; 1972 Aug; 51(8):2077-84. PubMed ID: 4626582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat.
    Theodoropoulos T; Braverman LE; Vagenakis AG
    J Clin Invest; 1979 Apr; 63(4):588-94. PubMed ID: 108290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
    Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
    J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Thyrotropin-Releasing Hormone Analog for Protracted Disturbance of Consciousness due to Aneurysmal Subarachnoid Hemorrhage.
    Shibata A; Matano F; Fujiki Y; Mizunari T; Murai Y; Yokota H; Morita A
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):988-993. PubMed ID: 30660483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V; Vescovi PP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
    Westwood ME; Butler GE; McLellan AC; Barth JH
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and CNS effects of oral and I.V. Thyrotropin-releasing hormone in depressed patients.
    Itil TM; Patterson CD; Polvan N; Bigelow A; Bergey B
    Dis Nerv Syst; 1975 Sep; 36(9):529-36. PubMed ID: 809253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotrophin releasing hormone.
    Sheth JJ; Thakore PB; Trivedi BB; Shah NN; Vaidya RA
    J Assoc Physicians India; 1999 Mar; 47(3):275-9. PubMed ID: 10999119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.